Contact: Diana Yates
University of Illinois at Urbana-Champaign
Caption: After promising trials in mice, the researchers tested their compound, called S-PAC-1, on dogs. The drug arrested tumor growth in three of six dogs with lymphoma, and induced partial remission of tumors in a fourth, with minimal side effects. This dog, a Walker Tree Hound named Hoover, is a healthy research dog used to help determine the best dosing strategy for S-PAC-1. (Veterinary clinical medicine professor Tim Fan adopted Hoover at the completion of the study.)
Credit: Photo by L. Brian Stauffer, U. of I. News Bureau.
Usage Restrictions: Photo may be used only with stories about the research described in the news release. Please credit: Photo by L. Brian Stauffer, U. of I. News Bureau.
Related news release: New lymphoma treatment shows promise in dogs